This medication has been manufactured as a liquid and is packaged in a vial
GHK-Cu addresses the same underlying process at the molecular level, by restoring one of the bodys own signaling molecules rather than physically injuring tissue to force a repair response
Specifically, an initial reduction followed by a substantial increase in beta-endorphin levels was observed, a pattern that suggests DSIPs impact on the opioidergic system, potentially playing a role in stress alleviation or adaptation processes
Cautious use of parenteral cyanocobalamin is also recommended in patients with renal impairment, including premature neonates, because of the possibility of greater aluminum accumulation, which may cause central nervous system and bone toxicity
Convincing evidence that increased dietary intake of choline or betaine could benefit cardiovascular health through lowering homocysteine concentrations in the blood is presently lacking
Food and Drug Administration (FDA) for therapeutic use